الأحاديث التي خطأ فيها ابن القطان الفاسي )ت: 628 ه( عبد الحق الإشبيلي )ت: 581 ه( في كتابه بيان الوهم والإيهام ، باب : ذكر أَحَادِيث أوردهَا مَوْقُوفَة، وَهِي مَرْفُوعَة دراسة نقدية. (Arabic)

Autor: د. سامي عواد بدوي 

Publikováno v: Journal of The Iraqi University; 2020, Vol. 46 Issue 1, p51-68, 18p

Treatment experiences with focus on IL-6R inhibition in patients with VEXAS-syndrome and a case of remission with azacytidine treatment.

Autor: Johansen MM; Department of Hematology, Copenhagen University Hospital, Copenhagen, Denmark.; Biotech Research and Innovation Center (BRIC), University of Copenhagen, Copenhagen, Denmark.; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., El Fassi D; Department of Hematology, Copenhagen University Hospital, Copenhagen, Denmark.; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Nielsen CTH; Center for Rheumatology and Spine Diseases, Copenhagen University Hospital, Copenhagen, Rigshospitalet, Denmark., Krintel SB; Center for Rheumatology and Spine Diseases, Copenhagen University Hospital, Copenhagen, Rigshospitalet, Denmark., Graudal N; Center for Rheumatology and Spine Diseases, Copenhagen University Hospital, Copenhagen, Rigshospitalet, Denmark., Hansen JW; Department of Hematology, Copenhagen University Hospital, Copenhagen, Denmark.; Biotech Research and Innovation Center (BRIC), University of Copenhagen, Copenhagen, Denmark.; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

Publikováno v: Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2023 Dec 23. Date of Electronic Publication: 2023 Dec 23.

The multidisciplinary approach to eosinophilia.

Autor: Thomsen GN; Department of Hematology, Odense University Hospital, Odense, Denmark., Christoffersen MN; Department of Hematology, Odense University Hospital, Odense, Denmark., Lindegaard HM; Department of Rheumatology, Odense University Hospital, Denmark; Research Unit for Rheumatology, Odense University Hospital, Odense, Denmark; University of Southern Denmark, Odense, Denmark., Davidsen JR; Department of Respiratory Medicine, Odense University Hospital, Denmark; Odense Respiratory Research Unit (ODIN), Department of Clinical Research, University of Southern Denmark, Odense, Denmark., Hartmeyer GN; Department of Clinical Microbiology, Odense University Hospital, Odense, Denmark., Assing K; Department of Clinical Immunology, Odense University Hospital, Odense, Denmark., Mortz CG; Department of Dermatology and Allergy Centre, Odense Research Centre for Anaphylaxis (ORCA), Odense University Hospital, Denmark; University of Southern Denmark, Odense, Denmark., Martin-Iguacel R; Department of Infectious Diseases , Odense University Hospital, Odense, Denmark., Møller MB; Department of Pathology, Odense University Hospital, Odense, Denmark., Kjeldsen AD; Department of ORL- Head and Neck Surgery and Audiology, Odense University Hospital, Odense, Denmark; University of Southern Denmark, Odense, Denmark., Havelund T; Department of Gastroenterology and Hepatology, Odense University Hospital, Odense, Denmark., El Fassi D; Department of Hematology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark., Broesby-Olsen S; Department of Dermatology and Allergy Centre, Odense Research Centre for Anaphylaxis (ORCA), Odense University Hospital, Denmark; University of Southern Denmark, Odense, Denmark., Maiborg M; Department of Cardiology, Odense University Hospital, Odense, Denmark., Johansson SL; Department of Respiratory Medicine, Odense University Hospital, Odense, Denmark., Andersen CL; Department of Hematology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.; Centre for General Practice, Department of Public Health, University of Copenhagen, Copenhagen, Denmark., Vestergaard H; Department of Hematology, Odense University Hospital, Odense, Denmark., Bjerrum OW; Department of Hematology, Odense University Hospital, Odense, Denmark.

Publikováno v: Frontiers in oncology [Front Oncol] 2023 May 18; Vol. 13, pp. 1193730. Date of Electronic Publication: 2023 May 18 (Print Publication: 2023).

An arginase1- and PD-L1-derived peptide-based vaccine for myeloproliferative neoplasms: A first-in-man clinical trial.

Autor: Grauslund JH; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Holmström MO; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.; Institute for Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark., Martinenaite E; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.; Research and Development, IO Biotech ApS, Copenhagen, Denmark., Lisle TL; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Glöckner HJ; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., El Fassi D; Department of Hematology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark., Klausen U; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.; Department of Hematology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark., Mortensen REJ; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Jørgensen N; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Kjær L; Department of Hematology, Zealand University Hospital, Roskilde, Denmark., Skov V; Department of Hematology, Zealand University Hospital, Roskilde, Denmark., Svane IM; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Hasselbalch HC; Department of Hematology, Zealand University Hospital, Roskilde, Denmark., Andersen MH; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.; Institute for Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.

Publikováno v: Frontiers in immunology [Front Immunol] 2023 Feb 23; Vol. 14, pp. 1117466. Date of Electronic Publication: 2023 Feb 23 (Print Publication: 2023).

Effects of empagliflozin on erythropoiesis in heart failure: data from the Empire HF trial.

Autor: Fuchs Andersen C; Department of Cardiology, Herlev and Gentofte University Hospital, Herlev, Denmark., Omar M; Department of Cardiology, Odense University Hospital, Odense, Denmark.; Steno Diabetes Center Odense, Odense, Denmark., Glenthøj A; Department of Haematology, Centre for Cancer and Organ Diseases, Rigshospitalet, Copenhagen, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark., El Fassi D; Department of Haematology, Centre for Cancer and Organ Diseases, Rigshospitalet, Copenhagen, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark., Møller HJ; Department of Clinical Biochemistry, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Lindholm Kurtzhals JA; Department of Clinical Microbiology, Centre of Medical Parasitology, Copenhagen University Hospital, Copenhagen, Denmark., Styrishave B; Toxicology and Drug Metabolism Group, Department of Pharmacy, University of Copenhagen, Copenhagen, Denmark., Kistorp C; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.; Department of Endocrinology, Rigshospitalet, Copenhagen, Denmark., Tuxen C; Department of Cardiology, Bispebjerg and Frederiksberg University Hospital, Copenhagen, Denmark., Poulsen MK; Department of Cardiology, Odense University Hospital, Odense, Denmark., Faber J; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.; Department of Internal Medicine, Centre of Endocrinology and Metabolism, Herlev and Gentofte University Hospital, Herlev, Denmark., Køber L; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.; Department of Internal Medicine, Centre of Endocrinology and Metabolism, Herlev and Gentofte University Hospital, Herlev, Denmark., Gustafsson F; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.; Department of Cardiology, Rigshospitalet, Copenhagen, Denmark., Møller JE; Department of Cardiology, Odense University Hospital, Odense, Denmark.; Department of Cardiology, Rigshospitalet, Copenhagen, Denmark.; Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark., Schou M; Department of Cardiology, Herlev and Gentofte University Hospital, Herlev, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark., Jensen J; Department of Cardiology, Herlev and Gentofte University Hospital, Herlev, Denmark.

Publikováno v: European journal of heart failure [Eur J Heart Fail] 2023 Feb; Vol. 25 (2), pp. 226-234. Date of Electronic Publication: 2022 Dec 14.